WallStreetZenWallStreetZen

NASDAQ: BPTH
Bio Path Holdings Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for BPTH

Based on 1 analyst offering 12 month price targets for Bio Path Holdings Inc.
Min Forecast
$9.00+160.12%
Avg Forecast
$9.00+160.12%
Max Forecast
$9.00+160.12%

Should I buy or sell BPTH stock?

Based on 1 analyst offering ratings for Bio Path Holdings Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BPTH stock forecasts and price targets.

BPTH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Top 5%
96
BuyMaintains$9.00+160.12%2022-05-19

1 of 1

Forecast return on equity

Is BPTH forecast to generate an efficient return?
Company
-59.06%
Industry
-11.33%
Market
100.32%
BPTH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BPTH forecast to generate an efficient return on assets?
Company
-54.87%
Industry
-5.09%
BPTH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BPTH earnings per share forecast

What is BPTH's earnings per share in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$1.76
Avg 2 year Forecast
-$1.61

BPTH vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BPTH$3.46$9.00+160.12%Buy
APTX$0.36$2.60+614.29%Buy
TNXP$0.57$0.60+5.08%Buy
BWV$1.79N/AN/A
ATNF$0.67N/AN/AHold

Bio Path Holdings Stock Forecast FAQ

Is Bio Path Holdings Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: BPTH) stock is to Buy BPTH stock.

Out of 1 analyst, 0 (0%) are recommending BPTH as a Strong Buy, 1 (100%) are recommending BPTH as a Buy, 0 (0%) are recommending BPTH as a Hold, 0 (0%) are recommending BPTH as a Sell, and 0 (0%) are recommending BPTH as a Strong Sell.

If you're new to stock investing, here's how to buy Bio Path Holdings stock.

What is BPTH's earnings growth forecast for 2022-2023?

(NASDAQ: BPTH) Bio Path Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 18.81%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 52.44%.

Bio Path Holdings's earnings in 2022 is -$12,552,000.On average, 2 Wall Street analysts forecast BPTH's earnings for 2022 to be -$12,601,889, with the lowest BPTH earnings forecast at -$13,389,507, and the highest BPTH earnings forecast at -$11,814,271.

In 2023, BPTH is forecast to generate -$11,527,864 in earnings, with the lowest earnings forecast at -$12,100,677 and the highest earnings forecast at -$10,883,449.

What is BPTH's forecast return on equity (ROE) for 2022-2023?

(NASDAQ: BPTH) forecast ROE is -59.06%, which is considered weak.

What is BPTH's Price Target?

According to 1 Wall Street analyst that have issued a 1 year BPTH price target, the average BPTH price target is $9.00, with the highest BPTH stock price forecast at $9.00 and the lowest BPTH stock price forecast at $9.00.

The Wall Street analyst predicted that Bio Path Holdings's share price could reach $9.00 by May 19, 2023. The average Bio Path Holdings stock price prediction forecasts a potential upside of 160.12% from the current BPTH share price of $3.46.

What is BPTH's Earnings Per Share (EPS) forecast for 2022-2023?

(NASDAQ: BPTH) Bio Path Holdings's current Earnings Per Share (EPS) is -$1.77. On average, analysts forecast that BPTH's EPS will be -$1.76 for 2022, with the lowest EPS forecast at -$1.87, and the highest EPS forecast at -$1.65. In 2023, BPTH's EPS is forecast to hit -$1.61 (min: -$1.69, max: -$1.52).

What is BPTH's forecast return on assets (ROA) for 2022-2023?

(NASDAQ: BPTH) forecast ROA is -54.87%, which is lower than the forecast US Biotechnology industry average of -5.09%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.